Pre-Seed Funding Statistics
Pre-seed funding statistics for 2026, covering SAFEs, valuation caps, check sizes, dilution math, accelerators, regional signals, and founder proof.
TL;DR: Pre-seed funding statistics for 2026 show an active but uneven market. Carta reported that U.S. pre-seed startups on its platform raised $10.4 billion through SAFEs and convertible notes in 2025, while the instrument count fell 13%. Carta also found a barbell pattern: sub-$250,000 pre-seed rounds reached 35% of rounds in Q4 2025, while rounds above $5 million stayed at 8%. Typical SAFE valuation caps stayed around $10 million for $250,000 to $1 million rounds and $15 million for $1 million to $2.5 million rounds. Elite accelerators remain brutally selective: Y Combinator says more than 10,000 companies apply every three months and it typically has a 1% acceptance rate. The founder takeaway is practical: pre-seed money rewards clear buyer pain, fast proof, clean terms, and a small use of funds that can turn into seed-quality evidence.
Pre-seed funding statistics tell founders something more useful than whether investors are “active.” They show how much proof an early company needs before money becomes leverage instead of expensive distraction.
In 2025, U.S.-based pre-seed startups on Carta raised $10.4 billion across 50,316 SAFEs and convertible notes. That sounds healthy until you read the second half of the sentence: total cash was almost flat from 2024, while the count of instruments fell 13%. Pre-seed is still moving, but the middle is getting squeezed.
Use this page with Mean CEO’s wider research on startup funding statistics by stage, seed funding statistics, startup runway statistics, and female founder funding statistics when you are deciding whether to raise, bootstrap longer, apply to an accelerator, or sell the first paid proof yourself.
Most Citeable Stats
Carta reported that U.S.-based pre-seed startups on its platform raised $10.4 billion across 50,316 SAFEs and convertible notes in 2025, with cash down 1% and instrument count down 13% from 2024.
In Q4 2025, pre-seed rounds below $250,000 reached 35% of rounds on Carta, while rounds above $5 million stayed around 8%.
Among SAFEs that raised at least $1 million, Carta said the average deal size reached $1.4 million in 2025, up from $1.1 million in 2024.
Carta’s 2025 pre-seed review said median post-money SAFE valuation caps hovered around $10 million for $250,000 to $1 million rounds and $15 million for $1 million to $2.5 million rounds.
Carta’s Q2 2025 report said U.S. pre-seed funding fell to $822 million in Q2 2025, down 25% from the prior quarter in that report, while convertible instrument count fell 17%.
Carta’s Q3 2025 report said the Western U.S. census region continued to take in about half of all U.S. pre-seed fundraising.
Y Combinator says more than 10,000 companies apply every three months and it typically has a 1% acceptance rate.
Carta’s State of Seed report says 92% of pre-seed rounds now use SAFEs, making SAFE literacy a basic founder skill.
Key Statistics
Carta’s Q1 2025 pre-seed report said U.S. pre-seed startups on Carta raised $737 million across 5,119 convertible instruments, down from $923 million across 6,251 instruments in Q4 2024.
Carta reported that Q1 2025 had about 3,400 pre-seed rounds under $1 million and 1,700 above $1 million, compared with nearly 3,800 under $1 million and 2,900 above $1 million in Q1 2024.
Carta said six of the top 20 U.S. pre-seed metros by cash raised from Q1 2023 to Q1 2025 were in the South: Austin, Dallas, Houston, D.C., Atlanta, and Miami.
Carta said the South took 18% of all U.S. pre-seed cash raised from Q1 2023 to Q1 2025.
Carta’s Q2 2025 report said pre-seed investment fell 25% by cash and 17% by instrument count from the prior quarter in that report.
Carta also said the majority of early-stage rounds under $4 million in the first half of 2025 were conducted on SAFEs or convertible notes instead of priced equity.
Carta’s Q3 2025 report said the first three quarters of 2025 had more rounds under $1 million and fewer rounds above $1 million than the same period in 2024.
Carta also said 2025 cash raised across rounds above $1 million was higher than in the same period of 2024, a capital concentration signal.
Carta’s Q3 2025 report said valuation caps for post-money SAFEs stayed mostly flat for most round sizes, while caps rose for large rounds of at least $2.5 million.
Carta said pre-seed healthtech startups raised $319 million year to date through Q3 2025, making healthtech the third-largest industry by cash invested and second-largest by round count on Carta.
Carta reported that healthtech pre-seed rounds of at least $2.5 million had a $35 million median valuation cap in Q3 2025 data.
Carta’s disappearing-middle analysis said rounds below $500,000 were 97% likely to be pre-seed rounds in 2025, and 93% of those pre-seed rounds were SAFEs.
Crunchbase reported that Q1 2026 global startup investment reached $300 billion across 6,000 startups, but that late-stage AI megadeals drove most of the headline total.
PitchBook and NVCA reported $267.2 billion in U.S. venture deal value in Q1 2026, and said the figure would fall 73.2% without the five largest deals.
Crunchbase said European startups raised $13.1 billion across more than 1,000 deals in Q3 2025, with early-stage funding accounting for roughly 60% of the regional total.
DocSend reported that investors spent 48% more time on business model sections and 25% more time on traction sections in 2023 pre-seed fundraising decks as risk tolerance tightened.
Pre-Seed Funding Snapshot
Pre-Seed Check Sizes And Dilution Math
These examples use simple post-money SAFE cap math for quick founder planning. Actual ownership can change when SAFEs convert, when option pools are created, when discounts apply, and when new priced-round money enters the cap table.
MeanCEO Index: Pre-Seed Funding Readiness For Bootstrapped Founders
The MeanCEO Index scores pre-seed paths from 1 to 10 through Mean CEO’s operator lens. It weighs customer access, proof speed, dilution risk, founder control, data clarity, investor selectivity, runway discipline, and how quickly a founder can turn money into paid evidence.
What The Numbers Mean For Bootstrapped Founders
Pre-seed capital should buy proof, not comfort.
For bootstrapped founders, the best use of pre-seed money is narrow: test one buyer type, one painful problem, one product promise, and one distribution channel. If the round cannot be connected to a specific proof milestone, it may be compensating for weak sales discipline.
The Carta data matters because it shows three pressures at once:
- Smaller checks are common, which means founders can raise less and keep moving.
- Larger checks are growing for specific categories, which means investors still chase exceptional upside.
- The middle is awkward, which means “normal” pre-seed can feel harder than founders expect.
For female founders and first-time founders, this is where documentation becomes power. Track the buyer calls. Record the objections. Show the manual workflow. Keep the cap table clean. Build a simple revenue bridge. Pre-seed investors may say they invest early, but they still reward founders who make the risk easier to understand.
Mean CEO Take
I do not treat pre-seed as a graduation ceremony. I treat it as a dangerous tool that can be very useful in the right hands.
A pre-seed round can buy time to build, hire, test, or open doors. It can also teach a founder to perform progress for investors before the market has said anything useful. That is where the damage starts.
The best pre-seed founders I respect have a small plan and a sharp definition of proof. They know what the money must make true. A signed pilot. A working prototype. A first paid workflow. A regulatory milestone. A sales process that survives outside the founder’s charisma.
For bootstrappers in Europe, and especially women who already get less margin for error, the practical move is simple: use constraints as proof. Spend slowly. Sell earlier. Keep clean evidence. If you raise, make the round serve the business. Investor interest is flattering, but customer money is harder to fake.
SAFEs And Convertible Notes Dominate Pre-Seed
Pre-seed funding is now mostly an unpriced financing market.
Carta’s 2025 pre-seed review counted 50,316 SAFEs and convertible notes for U.S.-based startups on Carta. Its State of Seed page says 92% of pre-seed rounds now use SAFEs. Carta’s disappearing-middle analysis adds another practical detail: among rounds under $500,000, 97% were pre-seed and 93% of those pre-seed rounds were SAFEs.
This matters because a SAFE is simple to sign and easy to misunderstand. A founder can collect small checks from angels, advisors, friends, and microfunds without seeing the full ownership impact until a priced round converts everything.
Use a conversion model before you sign. If you cannot explain the cap, discount, MFN rights, pro rata rights, and conversion scenario in plain English, you are negotiating from fog.
The Pre-Seed Market Is Becoming A Barbell
Carta’s 2026 disappearing-middle analysis described a widening split in the pre-seed market.
At the low end, rounds below $250,000 reached 35% of pre-seed rounds in Q4 2025. At the high end, rounds above $5 million stayed around 8%, and the average SAFE deal size among SAFEs raising at least $1 million rose to $1.4 million in 2025.
That is exactly the shape many founders feel: small checks are available, giant conviction checks go to special categories or special teams, and the middle requires more proof than the label “pre-seed” suggests.
AI has made this more intense. For software and fintech founders, AI can reduce early build costs. For AI infrastructure, healthtech, defense, robotics, and deep tech founders, AI can increase capital needs because compute, data, compliance, hardware, or expert talent are expensive.
Pre-Seed Regional Signals
The Bay Area and New York still matter, but pre-seed capital is more distributed than old startup maps suggest.
Carta’s Q3 2025 report said the Western U.S. census region continued to take in about half of U.S. pre-seed fundraising. Carta’s Q1 2025 report also highlighted Southern momentum: Austin, Dallas, Houston, D.C., Atlanta, and Miami appeared among the top 20 pre-seed metros by cash raised from Q1 2023 to Q1 2025, and the South took 18% of all pre-seed cash over that period.
Europe looks different. Crunchbase said European startups raised $13.1 billion across more than 1,000 deals in Q3 2025, with early-stage investment representing about 60% of regional funding. That is useful for European pre-seed founders because it shows early-stage resilience, but it also warns founders to prepare for a harder scale-up path later.
The operator lesson: raise where your buyer proof is strongest. A European founder should not automatically copy a Bay Area fundraising script. A founder in Atlanta, Amsterdam, Lisbon, Warsaw, or Malta can use remote selling, niche expertise, accelerators, grants, and customer-funded proof to create leverage before investor geography becomes a bottleneck.
Sector Signals At Pre-Seed
Carta’s Q3 2025 report singled out healthtech as a strong pre-seed category: healthtech pre-seed startups raised $319 million year to date, making it the third-largest Carta industry by cash invested and second-largest by round count. Carta also reported a $35 million median valuation cap for healthtech rounds of at least $2.5 million.
That does not make healthtech easy. It shows why sector context matters. A healthtech, biotech, defense, robotics, or deep-tech startup may need more capital before revenue because the proof is technical, regulated, or operational. A lightweight SaaS, no-code, AI workflow, creator tool, or marketplace should usually need less pre-seed capital to test demand.
For CADChain-style deep tech and IP-heavy startups, I look at pre-seed money differently than I do for simple software. Technical proof, grants, pilots, patents, compliance, and procurement access may justify a longer validation path. For a thin AI wrapper, I want a customer faster.
Founder Traction Benchmarks Before Pre-Seed
The strongest pre-seed proof usually fits one of five buckets:
- Buyer proof: a specific buyer segment has paid, signed, pre-ordered, or committed to a pilot.
- Problem proof: discovery calls show a repeated, painful, budget-connected problem.
- Product proof: a prototype, no-code MVP, manual service, or technical demo works well enough to test.
- Distribution proof: one channel can reach qualified buyers without heroic effort.
- Founder proof: the team has credible expertise, speed, technical ability, or unfair access.
DocSend’s fundraising research is useful here because it shows investor attention moving toward business model and traction. In its 2023 pre-seed deck analysis, investors spent 48% more time on business model sections and 25% more time on traction sections.
For a bootstrapped founder, that is a gift. You can build those sections with customer work before raising. Five paid pilots beat 50 vague “great idea” calls. Ten strong rejection notes with the same budget objection beat a pretty deck with no learning.
Practical Pre-Seed Readiness Checklist
Before raising pre-seed, write one sentence for each item:
- Buyer: who has the pain and budget?
- Pain: what happens if the buyer ignores the problem?
- Proof: what have they paid, used, signed, requested, or repeated?
- Use of funds: what will the pre-seed money make true in 6 to 12 months?
- Round size: what is the minimum capital needed to reach that proof?
- Instrument: SAFE, convertible note, grant, revenue, or customer-funded build?
- Dilution: what ownership is created by every check at conversion?
- Next round: what evidence would a seed investor need?
- No-round path: how does the company keep moving if investors say no?
If these answers are vague, delay the fundraising performance and get closer to customers.
Methodology
This article uses public startup funding datasets and startup fundraising sources available as of May 7, 2026. The core source is Carta’s pre-seed research for U.S.-based startups on Carta, including the 2025 annual review, Q1 2025, Q2 2025, Q3 2025, and the 2026 disappearing-middle analysis. Carta is used for pre-seed instruments, check-size distribution, SAFE adoption, valuation caps, regional signals, and sector-level examples.
Crunchbase, PitchBook/NVCA, and YC are used for market context. Crunchbase and PitchBook/NVCA show why headline venture funding in 2026 can be misleading for pre-seed founders because large AI and late-stage rounds dominate totals. Y Combinator is used as an accelerator selectivity and terms reference because many founders treat accelerators as a pre-seed path. DocSend is used for investor pitch-deck behavior.
The article keeps provider definitions separate. Carta’s figures cover companies and instruments on Carta, not the entire global pre-seed market. Crunchbase and PitchBook use their own venture datasets. Accelerator acceptance rates are selection proxies, not general pre-seed funding odds. All dilution examples are simple planning math and should be checked with a lawyer before signing financing documents.
Definitions
Pre-seed funding means the earliest outside capital used to test a startup idea, build an MVP, prove technical feasibility, validate a buyer, hire an early builder, or prepare for seed funding.
SAFE means Simple Agreement for Future Equity. It is an agreement that can convert into equity in a future financing round.
Convertible note means debt that can convert into equity later, usually with defined conversion terms such as a cap, discount, or maturity date.
Valuation cap means the maximum company valuation used to calculate SAFE or note conversion. Treat it as conversion math, not market proof.
Post-money SAFE means a SAFE where the ownership percentage can be calculated against the post-money valuation cap.
Pre-money valuation means the company valuation before new money enters in a priced round.
Dilution means the founder’s ownership percentage falls as new shares or conversion rights are issued.
Accelerator pre-seed means early capital plus program support, mentorship, investor access, and network signal, often in exchange for equity or SAFE terms.
Customer-funded proof means revenue, paid pilots, pre-orders, implementation fees, or services revenue used to validate demand before or alongside outside funding.
FAQ
How much pre-seed funding did startups raise in 2025?
U.S.-based pre-seed startups on Carta raised $10.4 billion across 50,316 SAFEs and convertible notes in 2025. Carta said cash invested was down 1% from 2024, while the count of instruments declined 13%.
What is a typical pre-seed valuation cap?
Carta’s 2025 pre-seed review said median post-money SAFE valuation caps hovered around $10 million for rounds between $250,000 and $1 million and $15 million for rounds between $1 million and $2.5 million.
How much dilution does a pre-seed SAFE create?
A simple post-money SAFE example is check size divided by valuation cap. A $500,000 SAFE on a $10 million post-money cap equals about 5% before later conversion mechanics, option pools, and new money.
Are SAFEs common at pre-seed?
Yes. Carta’s State of Seed page says 92% of pre-seed rounds now use SAFEs. Carta’s disappearing-middle analysis also said 93% of pre-seed rounds below $500,000 used SAFEs in 2025.
Is pre-seed funding easier in 2026?
Pre-seed is active, but not easy. Carta’s data shows flat cash with fewer instruments in 2025, plus a barbell market where small checks and very large checks are visible while the middle is harder.
What do investors want before pre-seed?
Investors usually want founder-market fit, a painful buyer problem, a credible product path, and evidence that the founder can turn a small amount of capital into seed-quality proof. DocSend’s research shows investors scrutinizing business model and traction more heavily in tighter markets.
Should bootstrapped founders raise pre-seed?
Raise pre-seed if the money buys a specific proof point faster than revenue alone. Keep bootstrapping longer if you can sell a pilot, build a no-code MVP, run paid discovery, or generate enough customer proof to raise later on better terms.
Is Y Combinator pre-seed funding?
Y Combinator is a common accelerator path for seed or pre-seed-stage companies. YC’s standard deal is $500,000 split into $125,000 for 7% on a post-money SAFE and $375,000 on an uncapped MFN SAFE.
